|
Ishbuldina A.V., Vakhitov K.M., Sabirova D.R., Karpova O.A., Shaimardanova G.R.
Clinical case of ROHHAD syndrome in pediatric practice
|
№7 / 2025
|
|
Efendieva R.M., Dikke G.B., Abusueva Z.A., Shilova N.V.
Pathogenetic aspects of menstrual and reproductive disorders in obese women
|
№3 / 2025
|
|
A.I. Tarzimanova, V.F. Valitova, K.O. Speranskaya, E.Sh. Samedova, A.A. Okhtova
Obesity and atrial fibrillation: new treatment options
|
№1 / 2025
|
|
E.A. Pigarova, L.K. Dzeranova
Status and features of vitamin D metabolism in obesity and its treatment
|
№1 / 2025
|
|
Kanavets N.S., Rebrova D.V.
Clinical cases of management of patients with type 2 diabetes mellitus using GLP-1 receptor agonists
|
№8 / 2024
|
|
Aramisova L.S., Zhurtova I.B., Akhkubekova Z.A.
Model for predicting the severity and outcome of COVID-19 in patients with diabetes mellitus and obesity, created based on artificial intelligence methods
|
№8 / 2024
|
|
Azizova K.V., Volkova A.R., Dora S.V., Zimina M.V., Ermoolinskaya T.S.
Features of folliculogenesis in women with different body mass index: a cross-sectional comparative study
|
№8 / 2024
|
|
Kurnikova I.A., Chekalina M.S., Ualikhanova A.U.
Optimization of approaches to the treatment of obesity in patients with type 2 diabetes mellitus
|
№8 / 2024
|
|
Vereshchagin E.I., Svechnikova E.V., Maksimova Yu.V., Arutyunyan G.B., Artemyeva N.O., Devyatova A.V.
Hyperuricemia as a marker of chronic systemic inflammation in the pathogenesis of psoriasis
|
№5 / 2024
|
|
Ostroumova O.D., Telkova S.S., Dubinina A.V., Klepikova M.V., Kochetkov A.I.
Non-alcoholic fatty liver disease as a trigger of polymorbidity. Is there a way out of the impasse?
|
№4 / 2024
|
|
Bulgakova S.V., Sharonova L.A., Kurmaev D.P., Treneva E.V., Kosareva O.V., Dolgikh Yu.A., Merzlova P.Ya.
Relationship between sarcopenic obesity and bone density in elderly patients
|
№2 / 2024
|
|
N.A. Korobkov, N.V. Bakulina, N.V. Borovik
Metabolic comorbidity of endometritis after caesarean section
|
№3 / 2023
|
Русский
